Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression

Gut

Volumn 62, Issue 9, 2013, Pages 1270-1279

  Weis, Victoria G ^a   Sousa, Josane F ^a   LaFleur, Bonnie J ^b   Nam, Ki Taek ^a   Weis, Jared A ^c   Finke, Paul E ^d   Ameen, Nadia A ^e   Fox, James G ^f   Goldenring, James R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GASTRIC METAPLASIA; HELICOBACTER FELIS; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTESTINE METAPLASIA; LASER CAPTURE MICRODISSECTION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPASMOLYTIC POLYPEPTIDE EXPRESSING METAPLASIA; STOMACH CANCER; STOMACH PARIETAL CELL; UPREGULATION;

CFTR; CHOLERA; CLUSTERIN; CYSTIC FIBROSIS; DIARRHOEAL DISEASE; DMP-777; GASTRIC CANCER; GASTROINTESTINAL CANCER; H PYLORI-PATHOGENESIS; HELICOBACTER FELIS; MOLECULAR PATHOLOGY; SPASMOLYTIC POLYPEPTIDE-EXPRESSING METAPLASIA; STEM CELLS; TREFOIL PEPTIDES;

ANIMALS; AZETIDINES; BIOLOGICAL MARKERS; CLUSTERIN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HELICOBACTER INFECTIONS; HUMANS; INFLAMMATION; INTESTINES; LASER CAPTURE MICRODISSECTION; METAPLASIA; MICE; MICE, INBRED CFTR; PARIETAL CELLS, GASTRIC; PEPTIDES; PIPERAZINES; PRECANCEROUS CONDITIONS; UP-REGULATION;

EID: 84881555481     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-302401     Document Type: Article

References (32)

1. Blaser M, Parsonnet J. Parasitism by the 'slow'' bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994;94:4-8.
2. Yoshizawa N, Takenaka Y, Yamaguchi H, et al. Emergence of spasmolytic polypeptide-expressing metaplasia in Mongolian gerbils infected with Helicobacter pylori. Lab Invest 2007;87:1265-76. (Pubitemid 350126706)
3. Nam KT, Lee HJ, Mok H, et al. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia. Gastroenterology 2009;136:1288-96.
4. Goldenring JR, Nam KT, Wang TC, et al. Spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia: time for reevaluation of metaplasias and the origins of gastric cancer. Gastroenterology 2010;138:2207-10; 2210.e1.
5. Nam KT, Lee HJ, Sousa JF, et al. Mature chief cells are cryptic progenitors for metaplasia in the stomach. Gastroenterology 2010;139:2028-37.e9.
6. Wang TC, Dangler CA, Chen D, et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000;118:36-47. (Pubitemid 30020371)
7. Houghton J, Stoicov C, Nomura S, et al. Gastric cancer originating from bone marrow-derived cells. Science 2004;306:1568-71. (Pubitemid 39564955)
8. Goldenring JR, Ray GS, Coffey RJ, et al. Reversible drug-induced oxyntic atrophy in rats. Gastroenterology 2000;118:1080-93. (Pubitemid 30346985)
9. Nomura S, Yamaguchi H, Ogawa M, et al. Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild type and gastrin deficient mice. Am J Physiol Gastrointest Liver Physiol 2004;288:G362-75. (Pubitemid 40129589)
10. Nozaki K, Ogawa M, Williams JA, et al. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss. Gastroenterology 2008;134:511-21.
11. Lee HJ, Nam KT, Park HS, et al. Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer. Gastroenterology 2010;139:213-25.e3.
12. Oshima M, Oshima H, Matsunaga A, et al. Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice. Cancer Res 2005;65:9147-51. (Pubitemid 41507975)
13. Fjeldbo CS, Bakke I, Erlandsen SE, et al. Gastrin upregulates the prosurvival factor secretory clusterin in adenocarcinoma cells and in oxyntic mucosa of hypergastrinemic rats. Am J Physiol Gastrointest Liver Physiol 2012;302:G21-33.
14. Collard MW, Griswold MD. Biosynthesis and molecular cloning of sulfated glycoprotein 2 secreted by rat Sertoli cells. Biochemistry 1987;26:3297-303.
15. McLaughlin L, Zhu G, Mistry M, et al. Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis. J Clin Invest 2000;106:1105-13.
16. Aronow BJ, Lund SD, Brown TL, et al. Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection. Proc Natl Acad Sci U S A 1993;90:725-9. (Pubitemid 23028938)
17. Ahuja HS, Tenniswood M, Lockshin R, et al. Expression of clusterin in cell differentiation and cell death. Biochem Cell Biol 1994;72:523-30.
18. Lee S, Hong SW, Min BH, et al. Essential role of clusterin in pancreas regeneration. Dev Dyn 2011;240:605-15.
19. Ameen N, Alexis J, Salas P. Cellular localization of the cystic fibrosis transmembrane conductance regulator in mouse intestinal tract. Histochem Cell Biol 2000;114:69-75. (Pubitemid 30609858)
20. McDaniel N, Pace AJ, Spiegel S, et al. Role of Na-K-2Cl cotransporter-1 in gastric secretion of nonacidic fluid and pepsinogen. Am J Physiol Gastrointest Liver Physiol 2005;289:G550-60. (Pubitemid 41216393)
21. Lee A, Fox JG, Otto G, et al. A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology 1990;99:1315-23. (Pubitemid 20381865)
22. Varon C, Dubus P, Mazurier F, et al. Helicobacter pylori infection recruits bone marrow-derived cells that participate in gastric preneoplasia in mice. Gastroenterology 2012;142:281-91.
23. Oshima H, Hioki K, Popivanova BK, et al. Prostaglandin E signaling and bacterial infection recruit tumor-promoting macrophages to mouse gastric tumors. Gastroenterology 2011;140:596-607.e7.
24. Fox JG, Blanco M, Murphy JC, et al. Local and systemic immune responses in murine Helicobacter felis active chronic gastritis. Infect Immun 1993;61:2309-15. (Pubitemid 23159216)
25. Keeley TM, Samuelson LC. Cytodifferentiation of the postnatal mouse stomach in normal and Huntingtin-interacting protein 1-related-deficient mice. Am J Physiol Gastrointest Liver Physiol 2010;299:G1241-51.
26. Katz JP, Perreault N, Goldstein BG, et al. Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology 2005;128:935-45. (Pubitemid 40523545)
27. Jain RN, Al-Menhali AA, Keeley TM, et al. Hip1r is expressed in gastric parietal cells and is required for tubulovesicle formation and cell survival in mice. J Clin Invest 2008;118:2459-70. (Pubitemid 351949774)
28. Oshima H, Oshima M, Inaba K, et al. Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO J 2004;23:1669-78. (Pubitemid 38579527)
29. Oshima H, Matsunaga A, Fujimura T, et al. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. Gastroenterology 2006;131:1086-95. (Pubitemid 44498691)
30. Ito K, Chuang LS, Ito T, et al. Loss of Runx3 is a key event in inducing precancerous state of the stomach. Gastroenterology 2011;140:1536-46.e8.
31. Rizzi F, Bettuzzi S. The clusterin paradigm in prostate and breast carcinogenesis. Endocr Relat Cancer 2010;17:R1-17.
32. Bi J, Guo AL, Lai YR, et al. Overexpression of clusterin correlates with tumor progression, metastasis in gastric cancer: a study on tissue microarrays. Neoplasma 2010;57:191-7.